Correlation of Bone Marrow Morphology and Immunophenotyping in Acute Leukaemia Patients

2020 ◽  
Vol 4 (02) ◽  
pp. 30-32
Author(s):  
Muhammad Nurul Farhad ◽  
Salma Afrose ◽  
Md. Sirajul Islam ◽  
Gazi Yeasinul Islam

Background: Acute leukaemia (AL) is a malignant disorder of the blood that is characterized by blocked or impaired differentiation of haemopoietic stem cells, resulting in abnormal accumulation of immature precursors and suppression of growth and maturation of cells in vivo. Objective: To find out correlation between morphological and immunophenotypic study of bone marrow among acute leukaemia patient. Methods/Procedure: This is a comparative cross sectional  study of diagnosis of leukaemia by bone marrow study and immunophenotyping from bone marrow sample with bone marrow alone of suspected cases of leukaemia treated in the department of haematology in Dhaka Medical College Hospital (DMCH)from March 2013 to August 2013 .Bone marrow examination and immunophenotyping was done simultaneously but having bone marrow morphology report we have compared with flow report. Results: Out of 50 patients according to Bone marrow study (BMS) 25(50.0%) of the patients had acute myelogenous leukaemia, 24(48.0%) had acute lymphoblastic leukaemia and 1(2.0%) had acute leukaemia. On the other hand, in immunophenotyping 28(56.0%) patients had acute lymphoblastic leukaemia, 20(40.0%) had acute myelogenous leukaemia and 2(4.0%) mixed cell immunophenotyping. Discordance of diagnosis was found in 3(6%) is diagnose as AML which was ALL on flow and one acute leukaemia and one AML was subsequently diagnose as mixed cellular leukaemia. Conclusion: Subjective variation in the accuracy of diagnosis of leukaemia on the basis of bone marrow study alone may occur. Inclusion of immunophenotyping with bone marrow study improves accuracy of leukaemia.

The Lancet ◽  
1983 ◽  
Vol 321 (8322) ◽  
pp. 467-468
Author(s):  
Robert Peter Gale ◽  
HumphreyE.M Kay ◽  
AlfredA Rimm ◽  
MortimerM Bortin

2011 ◽  
Vol 2011 ◽  
pp. 1-8 ◽  
Author(s):  
P. Schneider ◽  
I. Dubus ◽  
F. Gouel ◽  
E. Legrand ◽  
J. P. Vannier ◽  
...  

The role of angiogenesis in acute leukaemia has been discussed since the cloning of the gene ofvascular endothelial growth factor(VEGF) from the acute myelogenous leukemia cell line (HL60) and, thereafter, when the first studies reported increased bone marrow vascularity and elevation of angiogenic cytokines in acute lymphoblastic leukaemia (ALL). VEGF andbasic fibroblast growth factor(bFGF) are the major proangiogenic cytokines that have been studied, and evaluation of their prognostic impact in childhood ALL has been reported in several studies, though with controversial results. The antiangiogenic response, contributing to the angiogenic balance, has scarcely been reported. The origin of the factors, their prognostic value, and their relevance as good markers of what really happens in the bone marrow are discussed in this paper. The place of antiangiogenic drugs in ALL has to be defined in the global treatment strategy.


Sign in / Sign up

Export Citation Format

Share Document